HR 580
structure
Also Known As:
3-methyl-7-(4-(1,4,5,6-tetrahydro-2-pyrimidyl)phenylacetamido)-delta(3)-cephalosporanic acid; HR-580; 3-methyl-8-oxo-7- (((4-(1,4,5,6R-trans-tetrahydro-2- pyrimidinyl)phenyl)acetyl)amino)-5-thia- 1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
1. | Ventricular Dysfunction
03/01/2009
- " At 6 months, however, ventricular dysfunction was evident in TG (HR = 580 +/- 47 vs. 673 +/- 25 bpm, TG versus FVB, P < 0.05); LVSP (132 +/- 6 vs. 147 +/- 6 mmHg, TG versus FVB; P < 0.05); LVEDP (15 +/- 4 vs. 8 +/- 6 mmHg, TG vs. FVB, P < 0.05); +dp/dt = 8872 +/- 331 vs. 10026 +/- 796 mmHg/s TG versus FVB, P < 0.01) and -dp/dt (7403 +/- 432 vs. 8835 +/- 368 mmHg/s, TG versus FVB, P < 0.01; n = 8-12, in each group). "
|
|